Acute granulomatous interstitial nephritis in a patient with metastatic melanoma on targeted therapy with dabrafenib and trametinib

Acute granulomatous interstitial nephritis in a patient with metastatic melanoma on targeted therapy with dabrafenib and trametinib — A case report

Published:2021-08-05 Issue: Volume: Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

Krelle Anna¹,Mathai Vinod Kalapurackal²^ORCID,Kirkland Geoff¹,Nott Louise²,Jose Matthew D.¹³,Whale Karen⁴

Affiliation:

1. Department of Nephrology The Royal Hobart Hospital Hobart Tasmania Australia

2. Department of Oncology The Royal Hobart Hospital Hobart Tasmania Australia

3. School of Medicine The University of Tasmania Hobart Tasmania Australia

4. Department of Pathology The Royal Hobart Hospital Hobart Tasmania Australia

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1520

Reference16 articles.

1. Relative survival by stage Australian Government Cancer Australia Relative survival by stage at diagnosis (melanoma). National Cancer Control Indicatorshttps://www.canceraustralia.gov.au/

2. Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma

3. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

4. Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

5. Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits?;Clinical Liver Disease;2024-01

2. Truth or dare: switching BRAF/MEK inhibitors after acute interstitial nephritis in a patient with metastatic melanoma – A case report and review of the literature;Acta Clinica Belgica;2022-08-23

3. Dabrafenib/trametinib;Reactions Weekly;2022-08-20

4. Dabrafenib- and trametinib-associated glomerular toxicity;Medicine;2022-01-07

5. BRAF inhibition and the spectrum of granulomatous reactions;Journal of the American Academy of Dermatology;2021-10